{"id":"W2205491921","doi":"10.1001/jama.2015.16669","title":"Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma","year":2015,"lang":"en","type":"article","venue":"JAMA","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1226,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Mundipharma EDO; Genentech; Novocure; Merck KGaA","keywords":"Temozolomide; Medicine; Interim analysis; Clinical endpoint; Population; Chemoradiotherapy; Oncology; Internal medicine; Progression-free survival; Clinical trial; Radiation therapy; Chemotherapy; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001321119,0.0006390581,0.002251426,0.0005735176,0.0002450205,0.0006016816,0.000623416,0.0008350887,0.003239373],"category_scores_gemma":[0.001154812,0.0002756229,0.001088865,0.0003672516,0.0005439317,0.0008871158,0.0003657765,0.001666846,0.0003365701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001022008,"about_ca_system_score_gemma":0.001168597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007748156,"about_ca_topic_score_gemma":0.002100479,"domain_scores_codex":[0.9995731,0.000159414,0.00005196994,0.00007528138,0.00004810221,0.0000921665],"domain_scores_gemma":[0.9991918,0.000223445,0.0002018565,0.00005227649,0.00004042963,0.000290179],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9235063,0.01075252,0.002299451,0.0003912738,0.0006850807,0.0000434403,0.000063436,0.0006610354,0.006143139,0.0001557875,0.0007162907,0.0545822],"study_design_scores_gemma":[0.2241161,0.7486314,0.01665028,0.000146531,0.001891771,0.0001374201,0.00006906482,0.001914335,0.004333811,0.0004641365,0.001603336,0.00004190359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952728,0.002900959,0.0001736949,0.0001675075,0.0001918623,0.0004590384,0.0001862355,0.00002850498,0.0006193367],"genre_scores_gemma":[0.9964107,0.001389244,0.0003859951,0.0001743346,0.0002049319,0.0005659763,0.0002377531,0.000006552001,0.0006245159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003239373,"threshold_uncertainty_score":0.01083672,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02251928819661538,"score_gpt":0.2708430522898281,"score_spread":0.2483237640932127,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}